Banco Bilbao Vizcaya Argentaria S.A. Sells 11,069 Shares of Exelon Co. (NASDAQ:EXC)

Banco Bilbao Vizcaya Argentaria S.A. lowered its holdings in Exelon Co. (NASDAQ:EXC - Free Report) by 32.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,566 shares of the company's stock after selling 11,069 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Exelon were worth $887,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Adage Capital Partners GP L.L.C. boosted its position in shares of Exelon by 35.5% in the 4th quarter. Adage Capital Partners GP L.L.C. now owns 938,832 shares of the company's stock valued at $35,338,000 after purchasing an additional 246,200 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Exelon by 37.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company's stock worth $1,039,545,000 after buying an additional 7,483,873 shares during the period. Hsbc Holdings PLC increased its position in shares of Exelon by 25.6% in the fourth quarter. Hsbc Holdings PLC now owns 5,573,740 shares of the company's stock worth $209,748,000 after acquiring an additional 1,136,954 shares in the last quarter. Stifel Financial Corp raised its holdings in shares of Exelon by 2.4% during the fourth quarter. Stifel Financial Corp now owns 123,023 shares of the company's stock valued at $4,631,000 after acquiring an additional 2,854 shares during the period. Finally, Van Lanschot Kempen Investment Management N.V. purchased a new stake in shares of Exelon in the 4th quarter valued at approximately $7,434,000. 80.92% of the stock is currently owned by institutional investors.

Exelon Stock Down 0.6 %

EXC stock traded down $0.30 during trading hours on Thursday, hitting $46.60. The company's stock had a trading volume of 5,583,147 shares, compared to its average volume of 7,274,897. The stock has a 50 day moving average price of $44.95 and a two-hundred day moving average price of $41.18. Exelon Co. has a 12 month low of $34.01 and a 12 month high of $48.11. The company has a market capitalization of $47.04 billion, a PE ratio of 19.02, a price-to-earnings-growth ratio of 2.86 and a beta of 0.39. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.06. Exelon had a net margin of 10.68% and a return on equity of 9.52%. The firm had revenue of $6.71 billion during the quarter, compared to analysts' expectations of $6.30 billion. During the same period in the prior year, the company posted $0.68 earnings per share. Exelon's revenue for the quarter was up 11.1% on a year-over-year basis. On average, equities research analysts expect that Exelon Co. will post 2.64 earnings per share for the current year.

Exelon Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Monday, May 12th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, May 12th. This represents a $1.60 annualized dividend and a yield of 3.43%. Exelon's dividend payout ratio (DPR) is presently 65.31%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on EXC. Guggenheim set a $47.00 target price on shares of Exelon and gave the company a "buy" rating in a research note on Tuesday, April 22nd. Evercore ISI reissued an "in-line" rating and issued a $48.00 price objective (up from $46.00) on shares of Exelon in a research note on Tuesday, April 15th. Morgan Stanley lifted their target price on Exelon from $46.00 to $48.00 and gave the company an "equal weight" rating in a research note on Thursday, March 20th. Scotiabank increased their price target on shares of Exelon from $42.00 to $44.00 and gave the stock a "sector perform" rating in a research report on Thursday, February 13th. Finally, Barclays boosted their price objective on shares of Exelon from $42.00 to $48.00 and gave the company an "overweight" rating in a research report on Tuesday, February 25th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, Exelon has a consensus rating of "Hold" and a consensus target price of $46.67.

Insider Transactions at Exelon

In related news, EVP Colette D. Honorable sold 1,463 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the transaction, the executive vice president now owns 2,271 shares of the company's stock, valued at approximately $92,134.47. The trade was a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.10% of the stock is owned by corporate insiders.

Exelon Company Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.